Transcranial sonography in movement disorders
- PMID: 19219216
- DOI: 10.5507/bp.2008.039
Transcranial sonography in movement disorders
Abstract
Background: Transcranial sonography (TCS) in the B-mode has the ability to image, infratentorial and supratentorial brain structures. For this reason, it has potential use in the diagnosis and differential diagnosis of various intracranial pathologies.
Methods and results: The authors reviewed the contribution of TCS to the differentiation of a number of neurodegenerative diseases: in parkinsonian syndromes, TCS can evaluate echogenicity changes in specific structures such as the hyperechogenic area of the substantia nigra (SN) in Parkinson's disease and the hyperechogenic caudate nucleus in Huntington's disease as well as the hyperechogenic lentiform nucleus (LN) in dystonia and Wilson's disease. In parkinson-plus syndromes, TCS may detect changes in width of the third ventricle and of the frontal horns of the lateral ventricle. The hyperechogenic SN can also be used in healthy populations as a marker of subclinical injury to the nigrostriatal system.
Conclusion: TCS is a quick, safe and non-invasive method. It could be helpful in differentiation between several movement disorders together with clinical examination and other neuroimaging methods.
Similar articles
-
Transcranial Brain Sonography in Parkinson's Disease and Other Parkinsonian Disorders: a Hospital Study from Tuzla, Bosnia and Herzegovina.Med Arch. 2017 Aug;71(4):261-264. doi: 10.5455/medarh.2017.71.261-264. Med Arch. 2017. PMID: 28974846 Free PMC article.
-
Transcranial brain parenchyma sonography in movement disorders: state of the art.Ultrasound Med Biol. 2007 Jan;33(1):15-25. doi: 10.1016/j.ultrasmedbio.2006.07.021. Ultrasound Med Biol. 2007. PMID: 17189043 Review.
-
Substantia nigra echogenicity is normal in non-extrapyramidal cerebral disorders but increased in Parkinson's disease.J Neural Transm (Vienna). 2002 Feb;109(2):191-6. doi: 10.1007/s007020200015. J Neural Transm (Vienna). 2002. PMID: 12075859
-
Quantitative transcranial sonography in Wilson's disease and healthy controls: Cut-off values and functional correlates.J Neurol Sci. 2018 Feb 15;385:69-74. doi: 10.1016/j.jns.2017.11.026. Epub 2017 Nov 22. J Neurol Sci. 2018. PMID: 29406916
-
Transcranial sonography (TCS) of brain parenchyma in movement disorders: quality standards, diagnostic applications and novel technologies.Ultraschall Med. 2014 Aug;35(4):322-31. doi: 10.1055/s-0033-1356415. Epub 2014 Apr 24. Ultraschall Med. 2014. PMID: 24764215 Review.
Cited by
-
Clinical features and dysfunctions of iron metabolism in Parkinson disease patients with hyper echogenicity in substantia nigra: a cross-sectional study.BMC Neurol. 2018 Jan 17;18(1):9. doi: 10.1186/s12883-018-1016-5. BMC Neurol. 2018. PMID: 29343241 Free PMC article.
-
Diagnostic value of transcranial ultrasonography and clinical features for Parkinson's disease based on XGBoost model and SHAP visualization analysis: a retrospective study.Eur Radiol. 2025 Jul 3. doi: 10.1007/s00330-025-11789-6. Online ahead of print. Eur Radiol. 2025. PMID: 40610840
-
Transcranial sonography with clinical and demographic characteristics to predict cognitive impairment in PD: a longitudinal study.BMC Neurol. 2023 Jan 13;23(1):15. doi: 10.1186/s12883-023-03057-1. BMC Neurol. 2023. PMID: 36639620 Free PMC article.
-
A nomogram based on neuron-specific enolase and substantia nigra hyperechogenicity for identifying cognitive impairment in Parkinson's disease.Quant Imaging Med Surg. 2024 May 1;14(5):3581-3592. doi: 10.21037/qims-23-1778. Epub 2024 Apr 11. Quant Imaging Med Surg. 2024. PMID: 38720848 Free PMC article.
-
Spatial variations and precise location of substantia nigra hyperechogenicity in Parkinson's disease using TCS-MR fusion imaging.NPJ Parkinsons Dis. 2025 Apr 16;11(1):78. doi: 10.1038/s41531-025-00910-7. NPJ Parkinsons Dis. 2025. PMID: 40240329 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical